NAA OSEI-BEMPONG: Open Payments
NPI 1508640061 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $346 · 2025 $177
Food & beverage: $177
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $59 |
| Amgen Inc. | 1 | $31 |
| KYOWA KIRIN, INC. | 1 | $25 |
| Ardelyx, Inc. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Apellis Pharmaceuticals, Inc. | 1 | $15 |
Products named: TAVNEOS, JYNARQUE, CRYSVITA, IBSRELA, Kerendia.
Industry payments across TX — which companies pay providers there.
